Shanghai Jiaoda Onlly Co Ltd - Asset Resilience Ratio
Shanghai Jiaoda Onlly Co Ltd (600530) has an Asset Resilience Ratio of 0.82% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shanghai Jiaoda Onlly Co Ltd (600530) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Shanghai Jiaoda Onlly Co Ltd's Asset Resilience Ratio has changed over time. See 600530 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Jiaoda Onlly Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Shanghai Jiaoda Onlly Co Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥6.00 Million | 0.82% |
| Total Liquid Assets | CN¥6.00 Million | 0.82% |
Asset Resilience Insights
- Limited Liquidity: Shanghai Jiaoda Onlly Co Ltd maintains only 0.82% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Jiaoda Onlly Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shanghai Jiaoda Onlly Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
Drug Manufacturers - Specialty & Generic | 43.05% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277 |
Drug Manufacturers - Specialty & Generic | 31.63% |
|
Hainan Shuangcheng Pharmaceut
SHE:002693 |
Drug Manufacturers - Specialty & Generic | 3.29% |
Annual Asset Resilience Ratio for Shanghai Jiaoda Onlly Co Ltd (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Shanghai Jiaoda Onlly Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.97% | CN¥7.34 Million ≈ $1.07 Million |
CN¥758.88 Million ≈ $111.05 Million |
-0.31pp |
| 2023-12-31 | 1.28% | CN¥10.42 Million ≈ $1.52 Million |
CN¥815.10 Million ≈ $119.27 Million |
-0.08pp |
| 2022-12-31 | 1.36% | CN¥12.03 Million ≈ $1.76 Million |
CN¥884.83 Million ≈ $129.48 Million |
+0.46pp |
| 2021-12-31 | 0.90% | CN¥12.14 Million ≈ $1.78 Million |
CN¥1.35 Billion ≈ $197.89 Million |
-0.13pp |
| 2020-12-31 | 1.03% | CN¥13.29 Million ≈ $1.94 Million |
CN¥1.29 Billion ≈ $189.35 Million |
-1.08pp |
| 2019-12-31 | 2.11% | CN¥29.84 Million ≈ $4.37 Million |
CN¥1.42 Billion ≈ $207.18 Million |
+2.11pp |
| 2018-12-31 | 0.00% | CN¥23.42K ≈ $3.43K |
CN¥1.43 Billion ≈ $209.80 Million |
+0.00pp |
| 2017-12-31 | 0.00% | CN¥33.48K ≈ $4.90K |
CN¥2.26 Billion ≈ $330.80 Million |
-0.03pp |
| 2016-12-31 | 0.03% | CN¥778.30K ≈ $113.89K |
CN¥2.47 Billion ≈ $360.73 Million |
+0.03pp |
| 2015-12-31 | 0.01% | CN¥175.70K ≈ $25.71K |
CN¥2.69 Billion ≈ $393.34 Million |
+0.00pp |
| 2014-12-31 | 0.01% | CN¥151.34K ≈ $22.15K |
CN¥2.77 Billion ≈ $405.34 Million |
-0.06pp |
| 2013-12-31 | 0.06% | CN¥1.09 Million ≈ $159.45K |
CN¥1.79 Billion ≈ $262.37 Million |
-0.12pp |
| 2012-12-31 | 0.18% | CN¥3.29 Million ≈ $480.74K |
CN¥1.85 Billion ≈ $271.38 Million |
+0.14pp |
| 2011-12-31 | 0.04% | CN¥666.89K ≈ $97.59K |
CN¥1.69 Billion ≈ $247.94 Million |
-0.01pp |
| 2010-12-31 | 0.05% | CN¥674.45K ≈ $98.69K |
CN¥1.32 Billion ≈ $192.49 Million |
-0.03pp |
| 2009-12-31 | 0.08% | CN¥892.10K ≈ $130.54K |
CN¥1.13 Billion ≈ $164.70 Million |
+0.07pp |
| 2008-12-31 | 0.01% | CN¥142.38K ≈ $20.83K |
CN¥1.69 Billion ≈ $246.99 Million |
-0.12pp |
| 2007-12-31 | 0.12% | CN¥2.08 Million ≈ $304.60K |
CN¥1.68 Billion ≈ $245.16 Million |
+0.07pp |
| 2006-12-31 | 0.06% | CN¥1.02 Million ≈ $149.52K |
CN¥1.73 Billion ≈ $252.87 Million |
-0.13pp |
| 2003-12-31 | 0.19% | CN¥3.04 Million ≈ $444.35K |
CN¥1.60 Billion ≈ $234.82 Million |
-8.19pp |
| 2002-12-31 | 8.37% | CN¥112.16 Million ≈ $16.41 Million |
CN¥1.34 Billion ≈ $195.98 Million |
-4.94pp |
| 2001-12-31 | 13.32% | CN¥156.44 Million ≈ $22.89 Million |
CN¥1.17 Billion ≈ $171.90 Million |
+13.30pp |
| 2000-12-31 | 0.02% | CN¥77.87K ≈ $11.39K |
CN¥448.11 Million ≈ $65.57 Million |
-- |
About Shanghai Jiaoda Onlly Co Ltd
Shanghai Jiaoda Onlly Co.,Ltd, together with its subsidiaries, engages in the research, development, and production of raw materials and end products of food and health food in China. It is also involved in the operation and management of elderly medical care institutions, including hospitals and nursing homes; and the provision of management consulting services to non-profit hospitals, nursing h… Read more